ROBINSONS OF MAINE
LIVE

Serial Number

88858772

Owner

Mainely Legal LLC

Attorney

Robert Kimmer

First Use Date

Jul 17, 2020

Filing Date

Apr 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ROBINSONS OF MAINE Trademark

Serial Number: 88858772 • Registration: 7699365

ROBINSONS OF MAINE is a trademark filed by Mainely Legal LLC on April 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 34 (Smokers Articles). The application is currently registered and active.

Owner Contact Info

Mainely Legal LLC (3 trademarks)

263 China Road
Albion, ME 04910

Entity Type: 16

Trademark Details

Filing Date

April 3, 2020

Registration Date

February 18, 2025

First Use Anywhere

July 17, 2020

First Use in Commerce

September 20, 2020

Goods & Services

Medicinal drinks; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Medicinal infusions for treating a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Medicinal oils; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Medicinal roots; Medicinal syrups, namely, herbal extracts for the treatment of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Medicinal tea; Medicinal tea used for the treatment of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Pharmaceutical preparations for treatment and prevention of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, elixirs for the treatment of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Analgesic and muscle relaxant pharmaceutical preparations; Confectionery for medicinal purposes; Dietary and nutritional supplements, namely, oils and herbal extracts for treating a wide variety of medical ailments; Herbal pills and mixes for the psychological benefit of cleansing one's karma; Herbal pills for the treatment of diabetes; Herbal tinctures for medical purposes; Inhalers filled with oils and extracts for treating a wide variety of medical ailments; Medicated oils, namely, herbal extracts for treating a wide variety of medical ailments; Nose drops for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Sleeping pills/tablets; Veterinary pharmaceutical preparations for the prevention of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Veterinary pharmaceutical preparations for the treatment of a wide variety of medical ailments, namely, gastrointestinal diseases, psychiatric diseases, allergies, diabetes, anxiety, and pain; Vitamin drops; any cannabis in the aforementioned goods being featured or provided being solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0. 3 percent on a dry weight basis, and containing no CBD

Cigarette filters; Cigarette paper; Cigarette papers; Cigarette tubes; Cigarettes; Cigarettes and cigars; Cigarettes containing tobacco substitutes not for medical purposes; Cigarettes containing tobacco substitutes, not for medical purposes; Cartridges sold filled with chemical flavorings in liquid form for electronic cigarettes; Cartridges sold filled with propylene glycol for electronic cigarettes; Cartridges sold filled with vegetable glycerin for electronic cigarettes; Chemical flavorings in liquid form used to refill electronic cigarette cartridges; Electronic cigarette holders; Electronic cigarette liquid (e-liquid) comprised of flavorings in liquid form, other than essential oils, used to refill electronic cigarette cartridges; Electronic cigarette liquid (e-liquid) comprised of propylene glycol; Electronic cigarette liquid (e-liquid) comprised of vegetable glycerin; Electronic cigarettes and oral vaporizers for smokers; Mechanical electronic cigarettes; Oral vaporizers for smokers; Oral vaporizers for smoking purposes; Smokeless cigar vaporizer pipes; Smokeless cigarette vaporizer pipe; Smokers' oral vaporizer refill cartridges sold empty; any of the foregoing goods containing or for use with cannabis ingredients that are solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and containing no CBD

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Feb 18, 2025 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 28, 2025 CNTA
USE AMENDMENT ACCEPTED
Jan 28, 2025 IUAA
EXAMINER'S AMENDMENT ENTERED
Jan 28, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 28, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 28, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 28, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2024 DOCK
ASSIGNED TO EXAMINER
Dec 11, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2023 CRFA
ASSIGNED TO LIE
Nov 16, 2023 ALIE
NOTICE OF REVIVAL - E-MAILED
Nov 14, 2023 NREV
PETITION GRANTED - RESPONSE RECEIVED
Nov 14, 2023 PGRR
ASSIGNED TO PETITION STAFF
Nov 14, 2023 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 2, 2023 TROA
TEAS PETITION TO REVIVE RECEIVED
Oct 2, 2023 PROA
ASSIGNED TO EXAMINER
Oct 2, 2023 DOCK
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 18, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 18, 2023 ABN2
ASSIGNED TO EXAMINER
Sep 18, 2023 DOCK
AMENDMENT TO USE PROCESSING COMPLETE
Sep 16, 2023 AUPC
USE AMENDMENT FILED
Sep 16, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Sep 15, 2023 EAAU
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Jun 5, 2023 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Jun 5, 2023 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jun 5, 2023 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 5, 2023 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Mar 15, 2023 GNS1
SUBSEQUENT FINAL EMAILED
Mar 15, 2023 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Mar 15, 2023 CFRC
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 11, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 11, 2022 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 11, 2022 GNS1
SUBSEQUENT FINAL EMAILED
Jan 11, 2022 GNSF
SUBSEQUENT FINAL REFUSAL WRITTEN
Jan 11, 2022 CFRC
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 1, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 1, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 1, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 20, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 20, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2021 DOCK
ASSIGNED TO EXAMINER
Jan 14, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2020 NWOS
NEW APPLICATION ENTERED
Apr 7, 2020 NWAP